Skip to content

efficAcy and Safety of Home-baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs

A Perspective Randomized Controlled Clinical Trial to Investigate the Effect of Home-based Cardiac Rehabilitation Monitored by Mobile Phone Interaction on Exercise Capacity and One-year Clinical Outcome in Chinese Revascularized Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03102346
Acronym
ASSIST
Enrollment
2000
Registered
2017-04-05
Start date
2017-11-09
Completion date
2021-12-31
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

cardiorespiratory fitness, coronary artery disease, cardiac rehabilitation, remote control, major adverse cardiac and cerebrovascular events

Brief summary

Home-based CR (HBCR) was reported to improve the clinical outcomes of coronary artery disease (CAD) patients. There is no data published to investigate whether HBCR is also effective for Chinese CAD patients who have been revascularized. This trial was designed to investigate the safety and efficacy of CR program at home for Chinese patients who underwent PCI (Percutaneous Coronary Intervention) procedure. This is a multicenter, randomized, controlled and observational study.

Detailed description

Numerous studies have revealed that cardiac rehabilitation (CR) after myocardial Cardiac rehabilitation (CR) after revascularization results in better clinical outcomes, and have been strongly recommended for patients with coronary artery disease. In China, as compared to the exponential increase of PCI (Percutaneous Coronary Intervention) volume, only a very small amount of hospitals are able to develop CR programs. There is no large-scale study to explore the feasible CR pattern either. Home-based CR might be more favorable and practical for so many Chinese revascularized coronary artery disease (CAD) patients due to its feasibility and flexibility as well as low medical cost. This trial was designed to investigate the safety and efficacy of CR program at home for Chinese patients who underwent PCI procedure. This is a multicenter, randomized, controlled and observational study. The efficacy and safety of Home-based CR (HBCR) in revascularized patients will be evaluated through observation of its clinical characteristics and safety indicators. The study will involve 14 sites nationwide, with an expected sample size of 2,000 followed up for 12 months. The primary endpoints is the incidence of composite major adverse cardiac and cerebrovascular events (MACCE,death from any cause, nonfatal myocardial infarction, revascularization, stroke).Secondary endpoints are defined as decrease of hospitalization due to refractory angina pectoris,the improvements of cardiorespiratory fitness,life quality,as well as angina pectoris. The subjects will be randomized into 2 different groups, HBCR group and control group. After comprehensive evaluation, the orders from CR staff will be given. Besides the routine health education in both groups, the subjects in HBCR group will be further introduced the instructions of exercise training. The effect of HBCR on cardiorespiratory fitness, improvement of angina, cardiac function, quality of life, levels of anxiety and depression, as well as risk factor profile will also be evaluated. The investigators also aim to explore the factors which influence the adherence of subjects to our HBCR program.

Interventions

The exercise training includes aerobic exercise (fast walking or cycling ,30-40 minutes per day,5-6 times a week), stretching exercise (15 minutes every time, 5-6 times a week), and resistance and balance training (each of 15 minutes every time, twice to 3 times a week).

Sponsors

Chinese PLA General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

all of them 1. age range from 30 to 80. 2. coronary artery disease,revascularized with stent deployment. 3. New York Heart Association (NYHA) classification Class I-III. 4. Good cognitive level. 5. Ability to perform aerobic exercise. 6. Understand be able to use a mobile smart phone by himself or with help of family members. 7. Signature of informed consent. The informed consent will be valid for the duration of the trial or until the subject withdraws.

Exclusion criteria

(Enrollment): 1. Presence of malignant arrhythmias such as ventricular fibrillation outside the acute phase of Acute myocardial infarction (AMI) (\> 24 h after AMI), ventricular tachycardia, Atrioventricular block of 2nd degree and 3rd degree, Atrial fibrilation (FA) in patients with Wolf Parkinson White, fibrillation or paroxysmal atrial flutter with response ventricular quickly and hemodynamic deterioration, premature ventricular contractions increases during exertion, paroxysmal supraventricular tachycardia uncontrolled. 2. Hypotensive response to exercise. 3. acute myocardial infarction within 2 weeks 4. Poorly controlled hypertension baseline,hyperglycemia,respiratory failure. 5. severe pulmonary hypertension 6. acute phase of heart failure 7. Pathology of musculoskeletal, neurological or breathing that impair the ability of prolonged ambulation. 8. Pregnant women. 9. Subjects unable to give informed consent.

Design outcomes

Primary

MeasureTime frameDescription
MACCE(death, nonfatal myocardial infarction, revascularization, stroke)during 12 monthsdefined as the incidence of composite MACCE.

Secondary

MeasureTime frameDescription
improvement of hospitalization due to refractory angina pectorisduring 12 monthsimprovement of hospitalization due to refractory angina pectoris which need to be treated in hospital
improvement of cardiorespiratory fitnessduring 12 monthspeak oxygen uptake adjusted by body weight measured by cardiopulmonary exercise test
improvement of life qualityduring 12 monthsmeasured by medical outcomes study 36-item short form health survey
improvement of angina pectorisduring 12 monthsmeasured by Seattle Angina Questionnaire.

Countries

China

Contacts

Primary ContactJing Ma, MD,PHD
crystalma_301@126.com86-10-66935316

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026